We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05028751
Brief Title: A Study to Evaluate Lanraplenib (LANRA) in Combination With Gilteritinib in Participants With FLT3-mutated Relapsed or Refractory Acute Myeloid Leukemia (AML)

First Submitted : August 25, 2021
First Submitted that Met QC Criteria : August 25, 2021
First Posted : August 31, 2021

Last Update Submitted that Met QC Criteria : December 16, 2022
Last Update Posted : December 19, 2022